Search This Blog

Thursday, November 7, 2019

Ra Pharmaceuticals EPS misses by $0.05, beats on revenue

Ra Pharmaceuticals (NASDAQ:RARX): Q3 GAAP EPS of -$0.55 misses by $0.05.
Revenue of $3M beats by $2.62M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)